文献速递肺血管病与心包/心肌炎

miR-124/PTBP1/PKM轴调控肺动脉高压血管外膜成纤维细胞的代谢与增殖状态

Metabolic and Proliferative State of Vascular Adventitial Fibroblasts in Pulmonary Hypertension Is Regulated Through a MicroRNA-124/PTBP1 (Polypyrimidine Tract Binding Protein 1)/Pyruvate Kinase Muscle Axis.
PubMed 文献 · Circulation · 2017-09-26

该研究探讨肺动脉高压(PH)血管外膜成纤维细胞(PH-Fibs)代谢重编程的机制。在牛和人PH-Fibs中,PKM2/PKM1比值升高;抑制PKM2或通过miR-124过表达/PTBP1敲低恢复正常比值,可逆转糖酵解表型、改善线粒体功能并减少增殖。结论:miR-124经PTBP1调控PKM2/PKM1比值,影响细胞代谢、增殖和炎症状态。

要点

  • PH-Fibs中PKM2/PKM1比值升高,促进糖酵解和增殖。
  • miR-124过表达或PTBP1敲低可逆转糖酵解表型并减少增殖。
  • PKM2抑制或HDAC抑制剂产生类似代谢和增殖改善效果。

核心结论

  • 在肺动脉高压中,miR-124通过可变剪接因子PTBP1调控PKM2/PKM1比值,进而影响细胞的代谢、增殖和炎症状态。
  • 该PH表型可通过代谢级联不同层面的干预得以逆转。

研究设计与样本

  • 研究分离了严重PH的牛和人肺动脉外膜成纤维细胞(PH-Fibs)及正常受试者细胞进行体外实验。
  • 采用PTBP1-siRNA敲低PTBP1,miR-124 mimic恢复miR-124,TEPP-46和shikonin调控PKM2功能,组蛋白去乙酰化酶抑制剂处理细胞。
  • 代谢产物通过质谱代谢组学分析,线粒体功能通过共聚焦显微镜和荧光分光光度法分析。

主要发现

  • 与正常受试者相比,PH-Fibs中PKM2/PKM1比值升高。
  • 抑制PKM2逆转了PH-Fibs的糖酵解状态,降低细胞增殖,并减弱巨噬细胞白介素-1β表达。
  • 通过miR-124过表达或PTBP1敲低使PKM2/PKM1比值正常化,可逆转糖酵解表型(降低糖酵解中间产物和副产物如乳酸的产生),恢复线粒体重编程,并减少细胞增殖。
  • 使用TEPP-46和shikonin药理学调控PKM2活性或组蛋白去乙酰化酶抑制剂处理产生类似结果。

临床怎么用

  • 针对miR-124/PTBP1/PKM2轴可能为肺动脉高压提供新的治疗靶点。
  • PKM2抑制或HDAC抑制剂可能改善PH-Fibs的代谢和增殖异常。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: An emerging metabolic theory of pulmonary hypertension (PH) suggests that cellular and mitochondrial metabolic dysfunction underlies the pathology of this disease. We and others have previously demonstrated the existence of hyperproliferative, apoptosis-resistant, proinflammatory adventitial fibroblasts from human and bovine hypertensive pulmonary arterial walls (PH-Fibs) that exhibit constitutive reprogramming of glycolytic and mitochondrial metabolism, accompanied by an increased ratio of glucose catabolism through glycolysis versus the tricarboxylic acid cycle. However, the mechanisms responsible for these metabolic alterations in PH-Fibs remain unknown. We hypothesized that in PH-Fibs microRNA-124 (miR-124) regulates PTBP1 (polypyrimidine tract binding protein 1) expression to control alternative splicing of pyruvate kinase muscle (PKM) isoforms 1 and 2, resulting in an increased PKM2/PKM1 ratio, which promotes glycolysis and proliferation even in aerobic environments. METHODS: Pulmonary adventitial fibroblasts were isolated from calves and humans with severe PH (PH-Fibs) and from normal subjects. PTBP1 gene knockdown was achieved via PTBP1-siRNA; restoration of miR-124 was performed with miR-124 mimic. TEPP-46 and shikonin were used to manipulate PKM2 glycolytic function. Histone deacetylase inhibitors were used to treat cells. Metabolic products were determined by mass spectrometry-based metabolomics analyses, and mitochondrial function was analyzed by confocal microscopy and spectrofluorometry. RESULTS: We detected an increased PKM2/PKM1 ratio in PH-Fibs compared with normal subjects. PKM2 inhibition reversed the glycolytic status of PH-Fibs, decreased their cell proliferation, and attenuated macrophage interleukin-1β expression. Furthermore, normalizing the PKM2/PKM1 ratio in PH-Fibs by miR-124 overexpression or PTBP1 knockdown reversed the glycolytic phenotype (decreased the production of glycolytic intermediates and byproducts, ie, lactate), rescued mitochondrial reprogramming, and decreased cell proliferation. Pharmacological manipulation of PKM2 activity with TEPP-46 and shikonin or treatment with histone deacetylase inhibitors produced similar results. CONCLUSIONS: In PH, miR-124, through the alternative splicing factor PTBP1, regulates the PKM2/PKM1 ratio, the overall metabolic, proliferative, and inflammatory state of cells. This PH phenotype can be rescued with interventions at various levels of the metabolic cascade. These findings suggest a more integrated view of vascular cell metabolism, which may open unique therapeutic prospects in targeting the dynamic glycolytic and mitochondrial interactions and between mesenchymal inflammatory cells in PH.

来源:Circulation,查看原文。版权归原作者所有。

引用

  1. Zhang H, Wang D, Li M, et al. Metabolic and Proliferative State of Vascular Adventitial Fibroblasts in Pulmonary Hypertension Is Regulated Through a MicroRNA-124/PTBP1 (Polypyrimidine Tract Binding Protein 1)/Pyruvate Kinase Muscle Axis. Circulation. 2017. PMID: 28972001. doi:10.1161/CIRCULATIONAHA.117.028069

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。